![Next Science Limited logo](/logos/NXS.AX.webp)
Next Science Limited
ASX:NXS.AX
Overview | Financials
Company Name | Next Science Limited |
Symbol | NXS.AX |
Currency | AUD |
Price | 0.2 |
Market Cap | 58,432,000 |
Dividend Yield | 0% |
52-week-range | 0.18 - 0.5 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Harry Thomas Hall |
Website | https://www.nextscience.com |
An error occurred while fetching data.
About Next Science Limited
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD